Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16541480rdf:typepubmed:Citationlld:pubmed
pubmed-article:16541480lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16541480lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:16541480lifeskim:mentionsumls-concept:C0038013lld:lifeskim
pubmed-article:16541480lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:16541480lifeskim:mentionsumls-concept:C0023820lld:lifeskim
pubmed-article:16541480lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:16541480lifeskim:mentionsumls-concept:C0666743lld:lifeskim
pubmed-article:16541480lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:16541480lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:16541480pubmed:issue5lld:pubmed
pubmed-article:16541480pubmed:dateCreated2006-5-2lld:pubmed
pubmed-article:16541480pubmed:abstractTextTo investigate the longterm effects of the anti-tumor necrosis factor (TNF) therapy infliximab, a drug known to reduce disease activity in patients with rheumatoid arthritis (RA) and ankylosing spondylitis (AS).lld:pubmed
pubmed-article:16541480pubmed:languageenglld:pubmed
pubmed-article:16541480pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16541480pubmed:citationSubsetIMlld:pubmed
pubmed-article:16541480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16541480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16541480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16541480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16541480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16541480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16541480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16541480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16541480pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16541480pubmed:statusMEDLINElld:pubmed
pubmed-article:16541480pubmed:monthMaylld:pubmed
pubmed-article:16541480pubmed:issn0315-162Xlld:pubmed
pubmed-article:16541480pubmed:authorpubmed-author:DrososAlexand...lld:pubmed
pubmed-article:16541480pubmed:authorpubmed-author:NikasSpyros...lld:pubmed
pubmed-article:16541480pubmed:authorpubmed-author:KiortsisDimit...lld:pubmed
pubmed-article:16541480pubmed:authorpubmed-author:FilippatosThe...lld:pubmed
pubmed-article:16541480pubmed:authorpubmed-author:MavridisAnast...lld:pubmed
pubmed-article:16541480pubmed:authorpubmed-author:VasakosSpyros...lld:pubmed
pubmed-article:16541480pubmed:issnTypePrintlld:pubmed
pubmed-article:16541480pubmed:volume33lld:pubmed
pubmed-article:16541480pubmed:ownerNLMlld:pubmed
pubmed-article:16541480pubmed:authorsCompleteYlld:pubmed
pubmed-article:16541480pubmed:pagination921-3lld:pubmed
pubmed-article:16541480pubmed:dateRevised2006-9-12lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:meshHeadingpubmed-meshheading:16541480...lld:pubmed
pubmed-article:16541480pubmed:year2006lld:pubmed
pubmed-article:16541480pubmed:articleTitleEffects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.lld:pubmed
pubmed-article:16541480pubmed:affiliationDepartment of Internal Medicine, and the Rheumatology Clinic, Medical School, University of Ioannina, Ioannina, Greece. dkiorts@cc.uio.grlld:pubmed
pubmed-article:16541480pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16541480pubmed:publicationTypeClinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16541480lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16541480lld:pubmed